Search Count: 7
 |
Crystal Structure Of Human Nuak1-Mark3 Kinase Domain Chimera Bound With Small Molecule Inhibitor #10
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2024-10-23 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: EDO, NI, X4W |
 |
Crystal Structure Of Human Nuak1-Mark3 Kinase Domain Chimera Bound With Small Molecule Inhibitor #65
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2024-10-23 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: X3Q, EDO |
 |
Crystal Structure Of Human Nuak1-Mark3 (6 Mutations) Kinase Domain Chimera Bound With Small Molecule Inhibitor #31
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2024-10-23 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: X4H, EDO |
 |
Structure Of Keap1 Kelch Domain With (1S,2R)-2-{[(1S)-1-[(1,3-Dioxo-1,3-Dihydro-2H-Isoindol-2-Yl)Methyl]-3,4-Dihydroisoquinolin-2(1H)-Yl]Carbonyl}Cyclohexanecarboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2014-02-19 Classification: TRANSCRIPTION/INHIBITOR Ligands: ACT, 1VV, NA |
 |
Structure Of Keap1 Kelch Domain With 2-{[(1S)-2-{[(1R,2S)-2-(1H-Tetrazol-5-Yl)Cyclohexyl]Carbonyl}-1,2,3,4-Tetrahydroisoquinolin-1-Yl]Methyl}-1H-Isoindole-1,3(2H)-Dione
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2014-02-19 Classification: TRANSCRIPTION/INHIBITOR Ligands: 1VW, ACT |
 |
Structure Of Keap1 Kelch Domain With (1S,2R)-2-{[(1S)-5-Methyl-1-[(1-Oxo-1,3-Dihydro-2H-Isoindol-2-Yl)Methyl]-3,4-Dihydroisoquinolin-2(1H)-Yl]Carbonyl}Cyclohexanecarboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2014-02-19 Classification: TRANSCRIPTION/INHIBITOR Ligands: 1VX, ACT |
 |
Structure Of Keap1 Kelch Domain With(1S,2R)-2-[(1S)-1-[(1-Oxo-2,3-Dihydro-1H-Isoindol-2-Yl)Methyl]-1,2,3,4-Tetrahydroisoquinoline-2-Carbonyl]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2014-02-19 Classification: TRANSCRIPTION/INHIBITOR Ligands: 2FS, ACT |